Start Publications Quartz Crystal Microbalance with Dissipation (QCM-D) as tool to ...
Attension

Quartz Crystal Microbalance with Dissipation (QCM-D) as tool to exploit antigen-antibody interactions in pancreatic ductal adenocarcinoma detection

Year: 2013

Journal: Biosensors and bioelectronics, 2013, 42 pp 646-652, 20130115

Authors: Monica Bianco, Alessandra Aloisi, Valentina Arima, Michela Capello, Sammy Ferri-Borgogno, Francesco Novelli, Stefano Leporatti, Rosaria Rinaldi

Organizations: NNL - Institute of Nanoscience (NANO), CNR, Via per Arnesano 16, I-73100 Lecce, Italy, Center for Experimental Research and Medical Studies (CERMS) University of Turin San Giovanni Battista University Hospital via Cherasco 15, 10126 Turin, Italy, Department of Medicine and Experimental Oncology, University of Turin, Via Michelangelo 27, 10125 Torino, Italy, Università del Salento, Dipartimento di Matematica e Fisica “E. De Giorgi”, ex Collegio Fiorini Campus extraurbano, via per Arnesano, 73100, Lecce, Italy

Novel synthetic peptides represent smart molecules for antigen-antibody interactions in several bioanalytics applications, from purification to serum screening. Their immobilization onto a solid phase represents a key point for sensitivity increasing. In this view, we exploited Quartz Crystal Microbalance with simultaneous frequency and dissipation monitoring (QCM-D) with a double aim, specifically, as investigative tool for spacers monolayer assembling and its functional evaluation, as well as high sensitive method for specific immunosorbent assays. The method was applied to pancreatic ductal adenocarcinoma (PDAC) detection by studying the interactions between synthetic phosphorylated and un-phosphorylated α-enolase peptides with sera of healthy and PDAC patients. The synthetic peptides were immobilized on the gold surface of the QCM-D sensor via a self-assembled alkanethiol monolayer. The presented experimental results can be applied to the development of surfaces less sensitive to non-specific interactions with the final target to suggest specific protocols for detecting PDAC markers with unlabeled biosensors.